Frontiers in Immunology (May 2021)

Lysosome-Dependent LXR and PPARδ Activation Upon Efferocytosis in Human Macrophages

  • Ana Carolina Mota,
  • Monica Dominguez,
  • Andreas Weigert,
  • Ryan G. Snodgrass,
  • Dmitry Namgaladze,
  • Bernhard Brüne,
  • Bernhard Brüne,
  • Bernhard Brüne,
  • Bernhard Brüne

DOI
https://doi.org/10.3389/fimmu.2021.637778
Journal volume & issue
Vol. 12

Abstract

Read online

Efferocytosis is critical for tissue homeostasis, as its deregulation is associated with several autoimmune pathologies. While engulfing apoptotic cells, phagocytes activate transcription factors, such as peroxisome proliferator-activated receptors (PPAR) or liver X receptors (LXR) that orchestrate metabolic, phagocytic, and inflammatory responses towards the ingested material. Coordination of these transcription factors in efferocytotic human macrophages is not fully understood. In this study, we evaluated the transcriptional profile of macrophages following the uptake of apoptotic Jurkat T cells using RNA-seq analysis. Results indicated upregulation of PPAR and LXR pathways but downregulation of sterol regulatory element-binding proteins (SREBP) target genes. Pharmacological inhibition and RNA interference pointed to LXR and PPARδ as relevant transcriptional regulators, while PPARγ did not substantially contribute to gene regulation. Mechanistically, lysosomal digestion and lysosomal acid lipase (LIPA) were required for PPAR and LXR activation, while PPARδ activation also demanded an active lysosomal phospholipase A2 (PLA2G15). Pharmacological interference with LXR signaling attenuated ABCA1-dependent cholesterol efflux from efferocytotic macrophages, but suppression of inflammatory responses following efferocytosis occurred independently of LXR and PPARδ. These data provide mechanistic details on LXR and PPARδ activation in efferocytotic human macrophages.

Keywords